MedPath
TGA Approval

MYLANTA DOUBLE STRENGTH oral liquid bottle (reformulation 2) (126090)

126090

MYLANTA DOUBLE STRENGTH oral liquid bottle (reformulation 2)

Johnson & Johnson Pacific Pty Ltd

March 10, 2006

Medicine

Medicine

Active

Registered

Active Ingredients

aluminium hydroxide

aluminium hydroxide hydrate

magnesium hydroxide

simethicone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MYLANTA DOUBLE STRENGTH oral liquid bottle (reformulation 2) (126090) - TGA 批准文号 | MedPath